Neuberger Berman Group’s Galectin Therapeutics GALT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-11,614
Closed -$16.7K 1835
2023
Q2
$16.7K Hold
11,614
﹤0.01% 1783
2023
Q1
$24.4K Sell
11,614
-2,000
-15% -$3.23K ﹤0.01% 1777
2022
Q4
$15.4K Hold
13,614
﹤0.01% 1759
2022
Q3
$22K Hold
13,614
﹤0.01% 1805
2022
Q2
$18K Hold
13,614
﹤0.01% 1821
2022
Q1
$22K Hold
13,614
﹤0.01% 1877
2021
Q4
$28K Hold
13,614
﹤0.01% 1892
2021
Q3
$53K Hold
13,614
﹤0.01% 1734
2021
Q2
$44K Hold
13,614
﹤0.01% 1751
2021
Q1
$30K Sell
13,614
-4,575
-25% -$10.3K ﹤0.01% 1754
2020
Q4
$41K Sell
18,189
-55,730
-75% -$146K ﹤0.01% 1669
2020
Q3
$197K Sell
73,919
-5,575
-7% -$15.6K ﹤0.01% 1563
2020
Q2
$243K Hold
79,494
﹤0.01% 1443
2020
Q1
$156K Hold
79,494
﹤0.01% 1447
2019
Q4
$227K Hold
79,494
﹤0.01% 1449
2019
Q3
$292K Sell
79,494
-3,000
-4% -$10.8K ﹤0.01% 1382
2019
Q2
$342K Hold
82,494
﹤0.01% 1368
2019
Q1
$422K Hold
82,494
﹤0.01% 1296
2018
Q4
$283K Hold
82,494
﹤0.01% 1386
2018
Q3
$496K Hold
82,494
﹤0.01% 1322
2018
Q2
$525K Hold
82,494
﹤0.01% 1387
2018
Q1
$391K Hold
82,494
﹤0.01% 1404
2017
Q4
$276K Hold
82,494
﹤0.01% 1581
2017
Q3
$177K Hold
82,494
﹤0.01% 1551
2017
Q2
$203K Sell
82,494
-4,175
-5% -$11.1K ﹤0.01% 1524
2017
Q1
$199K Sell
86,669
-5,850
-6% -$8.82K ﹤0.01% 1540
2016
Q4
$91K Hold
92,519
﹤0.01% 1570
2016
Q3
$105K Hold
92,519
﹤0.01% 1562
2016
Q2
$136K Hold
92,519
﹤0.01% 1495
2016
Q1
$132K Hold
92,519
﹤0.01% 1450
2015
Q4
$152K Sell
92,519
-65,143
-41% -$149K ﹤0.01% 1456
2015
Q3
$369K Buy
157,662
+3,000
+2% +$7.07K ﹤0.01% 1342
2015
Q2
$422K Sell
154,662
-4,166
-3% -$12.6K ﹤0.01% 1363
2015
Q1
$532K Sell
158,828
-2,682
-2% -$9.58K ﹤0.01% 1333
2014
Q4
$560K Sell
161,510
-1,500
-0.9% -$6.63K ﹤0.01% 1331
2014
Q3
$819K Hold
163,010
﹤0.01% 1282
2014
Q2
$2.25M Buy
163,010
+1,650
+1% +$20.5K ﹤0.01% 1094
2014
Q1
$2.47M Sell
161,360
-47,250
-23% -$673K ﹤0.01% 1040
2013
Q4
$1.69M Sell
208,610
-58,390
-22% -$539K ﹤0.01% 1099
2013
Q3
$2.66M Sell
267,000
-6,800
-2% -$45.9K ﹤0.01% 989
2013
Q2
$1.16M Buy
+273,800
New +$1.12M ﹤0.01% 1154

Other funds holding GALT